Articles > Insulins & Non-insulins

  1. Lilly Asks FDA to Approve Nasal Glucagon for Use With People with Type 1 Diabetes

    If approved, it could have the potential to reshape how severe hypoglycemia is treated. -Craig Idlebrook/GluCraig UPDATE – 7/25/2018 – Lilly clarifies that they are asking for the FDA and the EMA to approve this drug for both people with both type 1 diabetes and people with type 2 diabetes to use.  Nasal glucagon is going […]

    Read More
  1. Nasal Glucagon Proves Effective in Real-World Conditions

    Trial participants also reported that the experimental glucagon was easy to use in the two late-phase trials. -Craig Idlebrook/GluCraig Data from two new studies provide evidence that nasal glucagon could be an effective treatment for hypoglycemia in a real-world setting. The two Phase III studies, funded by Eli Lilly and Locemia Solutions, aimed to gauge whether […]

    Read More
  2. FDA Agrees to Review Sotagliflozin for Type 1 Diabetes

    Sanofi has asked the FDA to approve the dual SGLT1 and SGLT2 inhibitor as a possible add-on to insulin therapy. By Craig Idlebrook/GluCraig Update: On May 22, 2018, the FDA has accepted Sanofi’s filing for sotagliflozin, which would be marketed as Zynquista. For more information, click here. You can read more about the oral drug below.  The FDA […]

    Read More
  3. Project Pizza: A Slice of T1D Research with GluAlex

    Has there ever been a food more beloved and yet more challenging for people with type 1 diabetes? Something about that high carb/high fat mix makes pizza both incredibly delicious and incredibly difficult to control blood sugar! Here at Glu, GluAlex attempted to find the right pizza bolus. Here’s what he learned: Project Pizza Night […]

    Read More
  1. Study Finds Stress May Increase Insulin Needs for People with Type 1 Diabetes


    Researchers found that higher stress levels were associated with higher post-meal blood glucose levels for people with type 1 diabetes. -Danielle Gianferante/GluDanielle According to a recent study, stress can affect blood glucose levels — but only after eating. For the University Hospital of Zurich study, forty participants (21 men, 19 women) with type 1 diabetes came […]

    Read More
  2. SGLT-2 Inhibitors Associated with DKA in Type 1 Patients, Warnings Now Required

    Close-up looking over a woman's shoulder to her holding a bottle of prescription medication

    The FDA recently mandated that users of SGLT-2 inhibitor drugs be warned of the risks of diabetic ketoacidosis (DKA) after receiving more than 70 reports of DKA. The agency previously issued a safety statement regarding these drugs’ potential dangerous side effects. SGLT-2 inhibitors, such as empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), are a promising […]

    Read More
  3. Steroid Medications Can Increase Insulin Requirements

    Vials of Pills

    Here’s what you need to know.  Type 1 diabetes (T1D) care, and particularly glycemic control, does not exist in a vacuum. Even if someone with T1D were to eat the exact same diet every day, his or her insulin requirements could still change. Exercise, stress, and environmental factors can have huge impacts on blood sugar […]

    Read More
  4. New Film Explains Monogenic Diabetes

    cover photo plain600

    An intriguing film was shown at this year’s ADA Scientific Sessions in Boston. Journey of a Miracle: Freedom from Insulin tells the story of several families who had children who were diagnosed with type 1 diabetes, but actually had monogenic diabetes. Dr. Louis Philipson of the University of Chicago introduced the film to the standing-room-only […]

    Read More
  5. FDA Issues Safety Statement that SGLT-2 Inhibitors May Cause Diabetic Ketoacidosis

    Anne Peters MD

    [Editor’s note: several months ago, we ran an article after Dr. Anne Peters of the University of Southern California reported some patients who took SGLT-2 inhibitors like Invokana off-label experienced diabetic ketoacidosis (DKA) while ill and even having evidently normal blood glucose levels. Our friends at diaTribe have posted an update after the FDA recently […]

    Read More
  6. Giving to Glu: A Supporter’s Story

    old needle

    Why support Glu? What’s in it for you? I have had type 1 diabetes for almost 47 years now. My family of eight was visiting relatives in the eighth month of 1968, when, at the age of 8, my life changed forever. I was taken to a small hospital in Lynchburg, Virginia, admitted with a […]

    Read More